title: Merck Completes $10B Acquisition of Verona Pharma, Adds COPD Drug Ohtuvayre
source: Yahoo
date: 2025-10-13
url: https://finnhub.io/api/news?id=877d9f14cb96b61ec96ca6d7dd6d929ddfa2ed5682f94b62b3fcfa4046ae52a4
Merck & Co. Inc. (NYSE:MRK) is one of the best growth stocks to buy now. On October 7, Merck & Co. announced the completion of its acquisition of Verona Pharma (NASDAQ:VRNA). Verona Pharma is now a wholly-owned subsidiary of Merck. The acquisition is valued at ~$10 billion and was executed under the terms of an [â€¦]
